Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 58 positions · Total reported value $123.01M · Top-10 concentration 62.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Stonepine Capital Management, LLC disclosed 58 equity positions with a combined reported value of $123.01M. The filing implies a focused portfolio: its ten largest positions account for 62.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were VSTM ($23.58M), ADMA ($10.83M), EOLS ($9.43M). By sector, the heaviest allocations are Health Care 88.7%, Information Technology 0.4%. Versus the prior quarter, allocation shifted toward Health Care (+3.9pp) and away from Other (-4.1pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 51% of names.

The largest new positions opened in Q3 2025 were XFOR ($3.61M), OABI ($3.43M), EDSA ($1.70M).

Of the 29 positions fully exited versus the prior quarter, the largest were ITOS ($3.09M), ANIP ($2.52M), ANIK ($2.02M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • XFOR X4 PHARMACEUTICALS INC · $3.61M
  • OABI OMNIAB INC · $3.43M
  • EDSA EDESA BIOTECH INC · $1.70M
  • SLNO SOLENO THERAPEUTICS INC · $1.62M
  • MNKD MANNKIND CORP · $846.15K
  • MXCT MAXCYTE INC · $725.25K
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $601.60K
  • AQST AQUESTIVE THERAPEUTICS INC · $562.35K

Fully Exited (vs previous quarter)

  • ITOS ITEOS THERAPEUTICS INC · prev qtr: $3.09M
  • ANIP ANI PHARMACEUTICALS INC · prev qtr: $2.52M
  • ANIK ANIKA THERAPEUTICS INC · prev qtr: $2.02M
  • YMAB Y-MABS THERAPEUTICS INC · prev qtr: $1.29M
  • COLL COLLEGIUM PHARMACEUTICAL INC · prev qtr: $1.23M
  • KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $1.13M
  • MYO MYOMO INC · prev qtr: $988.02K
  • XERS XERIS BIOPHARMA HOLDINGS INC · prev qtr: $957.82K

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 88.7%
Other 10.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.67M $23.58M 19.17%
19.17%
Add
2 739.00K $10.83M 8.81%
8.81%
Reduce
3 1.54M $9.43M 7.67%
7.67%
Add
4 810.00K $7.70M 6.26%
6.26%
Add
5 85.00K $4.84M 3.93%
3.93%
Add
6 647.38K $4.56M 3.71%
3.71%
Add
7 115.46K $4.45M 3.62%
3.62%
Reduce
8 174.54K $3.72M 3.03%
3.03%
Reduce
9 305.00K $3.65M 2.97%
2.97%
Reduce
10 1.06M $3.61M 2.94%
2.94%
New
11 2.14M $3.43M 2.79%
2.79%
New
12 250.15K $3.22M 2.62%
2.62%
Reduce
13 2.16M $3.21M 2.61%
2.61%
Add
14 100.00K $2.41M 1.96%
1.96%
Reduce
15 450.97K $2.38M 1.94%
1.94%
Add
16 1.60M $2.19M 1.78%
1.78%
Add
17 1.37M $1.92M 1.56%
1.56%
Add
18 687.50K $1.70M 1.38%
1.38%
New
19 891.86K $1.68M 1.36%
1.36%
Add
20 24.00K $1.62M 1.32%
1.32%
New
21 383.18K $1.49M 1.22%
1.22%
Add
22 300.00K $1.20M 0.97%
0.97%
Reduce
23 735.02K $1.19M 0.97%
0.97%
Hold
24 188.57K $1.11M 0.90%
0.90%
Add
25 200.00K $1.10M 0.90%
0.90%
Reduce
26 670.00K $1.09M 0.88%
0.88%
Add
27 108.09K $1.07M 0.87%
0.87%
Add
28 850.10K $1.07M 0.87%
0.87%
Add
29 195.00K $973.05K 0.79%
0.79%
Reduce
30 160.00K $913.60K 0.74%
0.74%
Add
31 157.57K $846.15K 0.69%
0.69%
New
32 459.02K $725.25K 0.59%
0.59%
New
33 563.91K $716.17K 0.58%
0.58%
Add
34 453.80K $685.24K 0.56%
0.56%
Add
35 60.00K $670.20K 0.55%
0.55%
Reduce
36 211.01K $628.18K 0.51%
0.51%
Reduce
37 20.00K $601.60K 0.49%
0.49%
New
38 37.20K $572.32K 0.47%
0.47%
Reduce
39 100.60K $562.35K 0.46%
0.46%
New
40 204.77K $538.54K 0.44%
0.44%
New
41 413.45K $508.55K 0.41%
0.41%
Add
42 155.55K $443.32K 0.36%
0.36%
Add
43 10.59K $433.88K 0.35%
0.35%
Add
44 289.24K $428.07K 0.35%
0.35%
New
45 125.00K $398.75K 0.32%
0.32%
New
46 140.60K $390.86K 0.32%
0.32%
Reduce
47 40.00K $376.00K 0.31%
0.31%
Reduce
48 192.90K $366.51K 0.30%
0.30%
Reduce
49 159.42K $345.94K 0.28%
0.28%
Add
50 20.00K $297.80K 0.24%
0.24%
New

FAQ

What did Stonepine Capital Management, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, Stonepine Capital Management, LLC reported 58 equity positions worth $123.01M in aggregate; its largest disclosed positions were VSTM ($23.58M), ADMA ($10.83M), EOLS ($9.43M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $123.01M of long equity holdings across 58 positions as of 2025-Q3. Top-10 holdings account for 62.1% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →